TABLE 5.
Detection of WN virus in human CSF specimens by NASBA, TaqMan, and RT-PCR assaysa
Sample no. | WN virus serologyb | NASBA-ECL assay result
|
TaqMan assay
|
RT-PCR result | ||
---|---|---|---|---|---|---|
ECL units | Interpretationc | CT value | Interpretationd | |||
1 | POS | 578,934 | POS | 35.7 | POS | NEG |
2 | POS | 65,745 | POS | 36.2 | POS | NEG |
3 | POS | 39 | NEG | 37 | POS | NEG |
4 | POS | 219,583 | POS | 38.3 | EQUIV | NEG |
5 | POS | 2,176 | POS | 39.3 | EQUIV | NEG |
6 | POS | 222,392 | POS | 45 | NEG | NEG |
7 | POS | 189,660 | POS | 39.67 | EQUIV | NEG |
8 | POS | 18,395 | POS | 35.2 | POS | NEG |
9 | POS | 35 | NEG | 45 | NEG | NEG |
10 | POS | 10 | NEG | 45 | NEG | NEG |
11–20 | All NEG | All <50 | All NEG | All 45 | All NEG | All NEG |
Abbreviations: POS, positive; NEG, negative; EQUIV, equivocal.
WN virus serology positive is defined as positivity by IgM and PRNT assay.
NASBA-ECL assay units >300 are interpreted as positive.
CT values <37 and Rn values greater than two times the average fluorescence for negative control samples is interpreted as a positive TaqMan assay result. For complete explanation of TaqMan assay: data interpretation, see Materials and Methods.